Conference Coverage

Consider biopsy for active lupus nephritis in pregnancy


 

EXPERT ANALYSIS AT KIDNEY WEEK 2014

References

If a biopsy is not possible, make an educated guess as to what you think is going on, and treat accordingly, he said.

“The consensus is that active disease is bad for both fetal and maternal outcomes, and that pregnancy makes lupus worse,” he said, noting that studies have shown that only about 10% of women with active disease achieve a term pregnancy, more than half have a preterm birth, and more than a third experience fetal loss.

Ideally, disease activity would be optimized prior to pregnancy in a patient with lupus, as outcomes are vastly improved by a quiescent disease state, but when this is not successful or possible and a patient presents with pregnancy and active disease, a biopsy should be considered, he said.

Dr. Fine said he had no relevant financial disclosures.

Pages

Recommended Reading

CDC sounds alarm on hospital antibiotic use
MDedge Rheumatology
FDA approves blood test for membranous glomerulonephritis
MDedge Rheumatology
New definition of clinically meaningful CKD progression
MDedge Rheumatology
Trial of sirukumab for lupus nephritis falls flat
MDedge Rheumatology
Hyponatremia linked to osteoporosis, fragility fractures
MDedge Rheumatology
Rituximab yielded long-term benefit in lupus nephritis
MDedge Rheumatology
One in six SLE patients readmitted in 30 days
MDedge Rheumatology
Later transplant for renal failure in lupus nephritis may raise graft failure risk
MDedge Rheumatology
Multitarget induction therapy superior over short term for lupus nephritis
MDedge Rheumatology
Azathioprine, mycophenolate mofetil ‘equally ineffective’ for lupus nephritis
MDedge Rheumatology